Löfdahl A, Rydell Törmänen K, Larsson Callerfelt A, Wenglén C, Westergren Thorsson G. Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro - a potential pathway affecting proliferation. Sci Rep. 2018;8:1927 pubmed publisher

Moutkine I, Quentin E, Guiard B, Maroteaux L, Doly S. Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers. J Biol Chem. 2017;292:6352-6368 pubmed publisher

Palmqvist N, Siller M, Klint C, Sjödin A. A human and animal model-based approach to investigating the anti-inflammatory profile and potential of the 5-HT2B receptor antagonist AM1030. J Inflamm (Lond). 2016;13:20 pubmed publisher

Tanaka T, Doe J, Horstmann S, Ahmad S, Ahmad A, Min S, et al. Neuroendocrine signaling via the serotonin transporter regulates clearance of apoptotic cells. J Biol Chem. 2014;289:10466-75 pubmed publisher

Chabbi Achengli Y, Launay J, Maroteaux L, de Vernejoul M, Collet C. Serotonin 2B receptor (5-HT2B R) signals through prostacyclin and PPAR-ß/? in osteoblasts. PLoS ONE. 2013;8:e75783 pubmed publisher

Söhle J, Machuy N, Smailbegovic E, Holtzmann U, Grönniger E, Wenck H, et al. Identification of new genes involved in human adipogenesis and fat storage. PLoS ONE. 2012;7:e31193 pubmed publisher

Murray K, Stephens M, Rank M, D Amico J, Gorassini M, Bennett D. Polysynaptic excitatory postsynaptic potentials that trigger spasms after spinal cord injury in rats are inhibited by 5-HT1B and 5-HT1F receptors. J Neurophysiol. 2011;106:925-43 pubmed publisher

Banas S, Doly S, Boutourlinsky K, Diaz S, Belmer A, Callebert J, et al. Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects. Neuropsychopharmacology. 2011;36:423-33 pubmed publisher